Related Experiment Video
Updated: Feb 9, 2026
Author Spotlight: Therapeutic Benefit of Closed-Loop Deep Brain Stimulation in Depression Treatment
Published on: July 7, 2023
Classical Risk Factors and Inflammatory Biomarkers: One of the Missing Biological Links between Cardiovascular
Thomas C Baghai1,2, Gabriella Varallo-Bedarida3, Christoph Born4
1Department of Psychiatry and Psychotherapy, Ludwig-Maximilian-University of Munich, Nußbaumstraße 7, D-80336 Munich, Germany. Thomas.Baghai@medbo.de.
Insights
Major depressive disorder (MDD) significantly increases cardiovascular risk, indicated by elevated inflammatory markers. Surprisingly, higher inflammation correlated with better antidepressant treatment outcomes, suggesting complex interactions between MDD and cardiovascular health.
Area of Science:
- Cardiology
- Psychiatry
- Immunology
Background:
- Cardiovascular disorders (CVD) and major depressive disorder (MDD) are leading global causes of mortality and disability.
- Both conditions share behavioral and immunological links, influencing their complex pathophysiology.
- Understanding these links is crucial for effective prevention and treatment strategies.
Purpose of the Study:
- To determine the frequency and severity of MDD in patients with CVD.
- To investigate if MDD, independent of CVD, impacts cardiovascular risk biomarkers.
- To explore the influence of proinflammatory cytokines on antidepressant treatment response.
Main Methods:
- A case-control study involving 310 adults: MDD patients (without CVD), CVD patients, and healthy controls.
- Assessment included clinical depression ratings (HAM-D), vital signs, cardiovascular risk factors, and inflammatory biomarkers.
- Comparison of biomarkers between MDD patients and healthy controls was performed.
Main Results:
- MDD patients exhibited increased cardiovascular risk, including prehypertension and metabolic syndrome indicators.
- Elevated inflammatory biomarkers (hsCRP, IL-1β, IL-6) were found in physically healthy MDD patients.
- Higher baseline inflammation markers were unexpectedly associated with better clinical outcomes and faster remission in MDD.
Conclusions:
- MDD patients face a specific risk for developing CVD, necessitating comprehensive cardiovascular risk assessment beyond traditional factors.
- The high prevalence of MDD in CVD patients underscores the need for integrated clinical attention.
- Further research into prophylactic interventions is essential for managing both MDD and CVD concurrently.
Background:
Cardiovascular disorders (CVD) and major depressive disorder (MDD) are the most frequent diseases worldwide responsible for premature death and disability. Behavioral and immunological variables influence the pathophysiology of both disorders. We therefore determined frequency and severity of MDD in CVD and studied whether MDD without CVD or other somatic diseases influences classical and inflammatory biomarkers of cardiovascular risk. In addition, we investigated the influence of proinflammatory cytokines on antidepressant treatment outcome.
Methods:
In a case-control design, 310 adults (MDD patients without CVD, CVD patients, and cardiologically and psychiatrically healthy matched controls) were investigated. MDD patients were recruited after admission in a psychiatric university hospital. Primary outcome criteria were clinical depression ratings (HAM-D scale), vital signs, classical cardiovascular risk factors and inflammatory biomarkers which were compared between MDD patients and healthy controls.
Results:
We detected an enhanced cardiovascular risk in MDD. Untreated prehypertension and signs directing to a metabolic syndrome were detected in MDD. Significantly higher inflammatory biomarkers such as the high sensitivity C-reaktive protein (hsCRP) and proinflammatory acute phase cytokines interleukine-1β (IL-1β) and interleukine-6 (IL-6) underlined the higher cardiovascular risk in physically healthy MDD patients. Surprisingly, high inflammation markers before treatment were associated with better clinical outcome and faster remission. The rate of MDD in CVD patients was high.
Conclusions:
Patients suffering from MDD are at specific risk for CVD. Precise detection of cardiovascular risks in MDD beyond classical risk factors is warranted to allow effective prophylaxis and treatment of both conditions. Future studies of prophylactic interventions may help to provide a basis for prophylactic treatment of both MDD and CVD. In addition, the high risk for MDD in CVD patients was confirmed and underlines the requirement for clinical attention.
More Related Videos
08:51Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
Published on: September 20, 2024
04:33Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
Published on: April 26, 2024
Related Concept Videos
01:27Depressive Disorders: Etiology
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
01:43Sex-linked Disorders
01:26Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
01:27Depressive Disorders: MDD and Dysthymia
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:27Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...